Update on attention deficit hyperactivity disorder

Journal of Paediatrics and Child Health

Volumn 47, Issue 10, 2011, Pages 682-689

  Efron, Daryl ^b,d,e   Hazell, Philip ^g,h,i   Anderson, Vicki ^a,c,f  

^a Integrated Mental Health Program   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Critical Care and Neurosciences Research   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e Department of Paediatrics ^*  (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h Child and Adolescent Mental Health Services Australia   (Australia)

ⁱ Thomas Walker Hospital   (Australia)

Author keywords

ADHD; behavioural intervention; education; stimulant medication; transition

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DEXMETHYLPHENIDATE; LISDEXAMFETAMINE; METHYLPHENIDATE; PLACEBO; PSYCHOSTIMULANT AGENT;

ALTERNATIVE MEDICINE; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; BEHAVIOR THERAPY; CLINICAL TRIAL; COMORBIDITY; CONDUCT DISORDER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MARKETING; EARLY INTERVENTION; EDUCATION; FAMILY; HUMAN; MENTAL HEALTH; MENTAL HEALTH CARE; NEUROBIOLOGY; OPPOSITIONAL DEFIANT DISORDER; PATIENT CARE; PEDIATRICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SOCIAL EVOLUTION; SYMPTOM; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUSTRALIA; BEHAVIOR THERAPY; HUMANS; RESEARCH;

EID: 80054822628     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01928.x     Document Type: Article

References (85)

1. Biederman J, Faraone S,. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237-48. (Pubitemid 40981053)
2. Wilens TE, Biederman J, Brown S, et al,. Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 2002; 41: 262-8. (Pubitemid 38338147)
3. Spencer TJ,. ADHD and comorbidity in childhood. J. Clin. Psychiatry 2006; 67: 27-31. (Pubitemid 44385604)
4. Nigg JT,. What Causes ADHD? New York, New York: The Guilford Press, 2006.
5. Faraone SV, Biederman J, Mick E,. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol. Med. 2006; 36: 159-65. (Pubitemid 43126140)
6. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M,. Adult psychiatric status of hyperactive boys grown up. Am. J. Psychiatry 1998; 155: 493-8. (Pubitemid 28207444)
7. Klassen A, Miller A, Fine S,. Health-related quality of life in children and adolescents who have a diagnosis of attention deficit/hyperactivity disorder. Pediatrics 2004; 114: 541-7.
8. Johnston C, Mash EJ,. Families of children with attention-deficit/ hyperactivity disorder: review and recommendations for future research. Clin. Child Fam. Psychol. Rev. 2001; 4: 183-207. (Pubitemid 33610771)
9. Rappley M,. Attention deficit-hyperactivity disorder. N. E. J. Med. 2005; 352: 165-73. (Pubitemid 40096613)
10. Prosser B,. ADHD: Who Is Failing Who?. Sydney: Finch Publishing, 2006.
11. Isaacs D,. ADHD: are we medicating for social disadvantage? (for) J. Paediatr. Child Health 2006; 42: 544-7.
12. Efron D,. ADHD: are we medicating for social disadvantage? (against). J. Paediatr. Child Health 2006; 42: 548-51.
13. Hiscock H, Efron D, Roberts G, et al,. A national snapshot of paediatric consultations: an Australian Paediatric Research Network study. J. Paediatr. Child Health 2009; 45: A1-A23.
14. Graetz BW, Sawyer MG, Hazell PL, Arney F, Baghurst P,. Validity of DSM-IV ADHD subtypes in a nationally representative sample of Australian children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2001; 40: 1410-17. (Pubitemid 34250960)
15. Rohde LA, Biederman J, Busnello EA, et al,. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J. Am. Acad. Child Adolesc. Psychiatry 1999; 38: 716-22. (Pubitemid 29250143)
16. Barbaresi WJ, Katusic SK, Colligan RC, et al,. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch. Pediatr. Adolesc. Med. 2002; 156: 217-24. (Pubitemid 34205431)
17. Smalley S, McGough J, Moilanen I,. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population. J. Am. Acad. Child Adolesc. Psychiatry 2007; 46: 1575-83. (Pubitemid 350146522)
18. Dopfner M, Breuer D, Wille N, et al,. How often do children meet ICD-10/DSM-IV criteria of attention-deficit/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates n a national sample-results of the BELLA study. Eur. Child Adolesc. Psychiatry 2008; 17: 59-70.
19. Barkley R,. Behavioural inhibition, sustained attention and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 1997; 121: 65-94. (Pubitemid 127705285)
20. Asherson P, Kuntsi J, Taylor E,. Unravelling the complexity of attention deficit hyperactivity disorder: a behavioural genomic approach. Br. J. Psychiatry 2005; 187: 103-5. (Pubitemid 41139680)
21. Castellanos FX, Tannock R,. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 2002; 3: 617-28. (Pubitemid 135706670)
22. Coghill D, Nigg J, Rothenberger A, Sonuga-Barke E, Tannock R,. Whither causal models in the neuroscience of ADHD? Dev. Sci. 2005; 8: 105-14. (Pubitemid 40344679)
23. Castellanos F, Sonuga-Barke E, Milham M, Tannock R,. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn. Sci. 2006; 10: 117-23.
24. Khan RS, Khoury J, Nichols WC, et al,. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J. Pediatr. 2003; 143: 104-10. (Pubitemid 36928576)
25. Sonuga-Barke E, Oades R, Psychogiou L, et al,. Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder. J. Child Psychol. Psychiatry 2009; 50: 1052-63.
26. AACAP. Practice parameter for attention deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 2007; 46: 894-921.
27. American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/ hyperactivity disorder. Pediatrics 2000; 105: 1158-70.
28. National Collaborating Centre for Mental Health. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. NICE clinical guideline 72. NHS National Institute for Health and Clinical Excellence. September 2008.
29. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance. Canadian ADHD Practice Guidelines. 2008.
30. Taylor E, Dopfner M, Sergeant J, et al,. European ethical guidelines for hyperkinetic disorder-first upgrade. Eur. Child Adolesc. Psychiatry 2004; 13 (Suppl. 1): 7-30.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
32. Castellanos F,. Analyses related to request for secondary data diagnostic criteria, in preparation of DSM-V. Eur. Child Adolesc. Psychiatry 2008; 17: 326.
33. Clinical Excellence Commission (CEC). Attention Deficit Hyperactivity Disorder in Children and Adolescents in New South Wales-2007, Final Report of the Special Review. Sydney, NSW: CEC, 2007.
34. Pliszka S,. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 2007; 46: 894-921.
35. Hazell PL, Lewin TJ, McDowell MJ, Walton JM,. Factors associated with medium-term response to psychostimulant medication. J. Paediatr. Child Health 1999; 35: 264-9.
36. Motta VL, Schachar RJ,. Reformulating attention-deficit/hyperactivity disorder according to signal detection theory. J. Am. Acad. Child Adolesc. Psychiatry 2000; 39: 1144-51.
37. MTA Cooperative Group. National institute of mental health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113: 754-61.
38. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Arch. Gen. Psychiatry 1999; 56: 1073-86.
39. Salmelainen P,. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales. NSW Public Health Bull., 2002; 13 (Suppl. 1): 1-65. NSW Department of Health.
40. Berbatis C, Sunderland V, Bulsara M,. Licit psychostimulant consumption in Australia 1984-2000: international and jurisdictional comparison. Med. J. Aust. 2002; 177: 539-43. (Pubitemid 35422816)
41. Calver J, Preen D, Bulsara M, Sanfilippo F,. Stimulant prescribing for the treatment of ADHD in Western Australia: socioeconomic and remoteness differences. Med. J. Aust. 2007; 186: 124-7. (Pubitemid 46322364)
42. Salmelainen P,. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in adults in NSW. NSW Public Health Bull. 2004; 15: 20-2.
43. Preen D, Calver J, Sanfilippo F, Bulsara M, D'Arcy J, Holman C,. Prescribing of psychostimulant medications for attention deficit hyperactivity disorder in children: differences between clinical specialties. Med. J. Aust. 2008; 188: 337-9.
44. Roongpraiwan R, Efron D, Sewell J, Mathai J,. Comparison of mental health symptoms between children attending developmental/behavioural paediatric clinics and child and adolescent mental health service. J. Paediatr. Child Health 2007; 43: 122-6. (Pubitemid 46213674)
45. Hechtman L, Greenfield B,. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr. Drugs 2003; 5: 787-94. (Pubitemid 38030604)
46. Biederman J, Monuteaux MC, Spencer T, et al,. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 2009; 124: 71-8.
47. Buitelaar JK, Danckaerts M, Gillberg C, et al,. A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur. Child Adolesc. Psychiatry 2004; 13: 249-57. (Pubitemid 39279157)
48. Safer D, Zito J,. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. In:, Greenhill L, Osman B, eds. Ritalin: Theory and Practice. Larchmant NY: Mary Ann Liebert, 2000; 7-26.
49. Hazell P,. In children with attention-deficit hyperactivity disorder who have been taking methylphenidate for at least 1 year, is there any evidence of harmful effects? Evid. Based Healthcare Public Health 2005; 9: 10-15. (Pubitemid 40267907)
50. Swanson JM, Elliott GR, Greenhill LL, et al,. For the MTA Cooperative Group: effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J. Am. Acad. Child Adolesc. Psychiatry 2007; 46: 1014-26.
51. Hechtman L, Weiss G,. Controlled prospective fifteen year follow-up of hyperactives as adults: non-medical drug and alcohol use and anti-social behaviour. Can. J. Psychiatry 1986; 31: 557-67. (Pubitemid 17172328)
52. Hechtman L, Weiss G, Perlman T,. Hyperactives as young adults: past and current substance abuse and antisocial behavior. Am. J. Orthopsychiatry 1984; 54: 415-25. (Pubitemid 14068135)
53. Hechtman L, Weiss G,. Long-term outcome of hyperactive children. Am. J. Orthopsychiatry 1983; 53: 532-41. (Pubitemid 13011810)
54. Hechtman L, Weiss G, Perlman T,. Hyperactives as young adults: past and current antisocial behavior (stealing, drug abuse) and moral development. Psychopharmacol. Bull. 1981; 17: 107-10.
55. Mannuzza S, Klein RG, Moulton JL, 3rd,. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res. 2008; 160: 237-46.
56. Mannuzza S, Klein RG, Konig PH, Giampino TL,. Hyperactive boys almost grown up. IV. Criminality and its relationship to psychiatric status. Arch. Gen. Psychiatry 1989; 46: 1073-9. (Pubitemid 20016444)
57. Rasmussen P, Gillberg C,. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J. Am. Acad. Child Adolesc. Psychiatry 2000; 39: 1424-31.
58. Howell DC, Huessy HR, Hassuk B,. Fifteen-year follow-up of a behavioral history of attention deficit disorder. Pediatrics 1985; 76: 185-90. (Pubitemid 15039900)
59. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M,. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 1993; 50: 565-76. (Pubitemid 23203567)
60. Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, Addalli KA,. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch. Gen. Psychiatry 1991; 48: 77-83.
61. Fayyad J, De Graaf R, Kessler R, et al,. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br. J. Psychiatry 2007; 190: 402-9. (Pubitemid 46706952)
62. Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N,. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Comp. Psychiatry 1990; 31: 416-25. (Pubitemid 20305300)
63. Weiss G, Hechtman L, Perlman T,. Hyperactives as young adults: school, employer, and self-rating scales obtained during ten-year follow-up evaluation. Am. J. Orthopsychiatry 1978; 48: 438-45. (Pubitemid 8375996)
64. Barkley RA, Fischer M, Smallish L, et al,. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J. Am. Acad. Child Adolesc. Psychiatry 2006; 45: 192-202. (Pubitemid 43151524)
65. Jerome L, Segal A, Habinski L,. What we know about ADHD and driving risk: a literature review, meta-analysis and critique. J. Can. Acad. Child Adolesc. Psychiatry 2006; 15: 105-25. (Pubitemid 44548802)
66. Kessler RC, Lane M, Stang PE, Van Brunt DL,. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol. Med. 2009; 39: 137-47.
67. Murray C, Johnston C,. Parenting in mothers with and without attention-deficit/hyperactivity disorder. J. Abnorm. Psychol. 2006; 115: 52-61.
68. Langberg JM, Epstein JN, Altaye M, Molina BSG, Arnold LE, Vitiello B,. The transition to middle school 'is associated with changes in the developmental trajectory of ADHD symptomatology in young adolescents with ADHD. J. Clin. Child Adolesc. Psychol. 2008; 37: 651-63.
69. Wong ICK, Asherson P, Bilbow A, et al,. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)-a pharmacoepidemiological and qualitative study. Health Technol. Assess. 2009; 13: 1-120.
70. Sinha D, Efron D,. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J. Paediatr. Child Health 2005; 41: 23-6. (Pubitemid 40223140)
71. Stubberfield T, Parry T,. Utilization of alternative therapies in attention-deficit hyperactivity disorder. J. Paediatr. Child Health 1999; 35: 450-3. (Pubitemid 29472839)
72. Schmidt MH, Mocks P, Lay B, et al,. Does oligoantigenic diet influence hyperactive/conduct-disordered children-a controlled trial. Eur. Child Adolesc. Psychiatry 1997; 6: 88-95.
73. Clayton EH, Hanstock TL, Garg ML, Hazell PL,. Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta. Neuropsychiatr. 2007; 19: 92-103. (Pubitemid 46596161)
74. Riccio CA, French CL,. The status of empirical support for treatments of attention deficits. Clin. Neuropsychol. 2004; 18: 528-58. (Pubitemid 40082826)
75. Hernandez-Reif M, Field TM, Thimas E,. Attention deficit hyperactivity disorder: benefits from Tai Chi. J. Bodyw. Mov. Ther. 2001; 5: 120-3. (Pubitemid 32238435)
76. Jensen PS, Kenny DT,. The effects of yoga on the attention and behavior of boys with attention-deficit/hyperactivity disorder (ADHD). J. Atten. Disord. 2004; 7: 205-16. (Pubitemid 38891299)
77. Altunc U, Pittler MH, Ernst E,. Homeopathy for childhood and adolescence ailments: systematic review of randomized clinical trials. Mayo Clin. Proc. 2007; 82: 69-75. (Pubitemid 46036323)
78. Barkley RA, Guevremont DC, Anastopoulos AD, et al,. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 1993; 92: 212-18. (Pubitemid 23226834)
79. Jerome L, Segal A, Habinski L,. What we know about ADHD and driving risk: literatute review, meta-analysis and critique. J. Can. Acad. Child Adolesc. Psychiatry 2006; 15: 105-25. (Pubitemid 44548802)
80. Efron D, Sciberras E, Hassell P,. Are schools meeting the needs of students with ADHD? Aust. J. Spe. Educ. 2008; 32: 187-98.
81. Loe IM, Feldman HM,. Academic and educational outcomes of children with ADHD. Ambul. Pediatr. 2007; 7: 82-90. (Pubitemid 46140760)
82. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M,. Adult outcome of hyperactive boys: I. Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 1993; 50: 565-76. (Pubitemid 23203567)
83. Rudolph S, Hiscock H, Price A, et al,. What research questions matter to Australian paediatricians? National Delphi Study. J. Paediatr. Child Health 2009; 45: 704-10.
84. Snowling M,. Multiple perspectives on ADHD: implications for future research. J. Child Psychol. Psychiatry 2009; 50: 1039-41.
85. Sciberras E, Roos L, Efron D,. Review of prospective longitudinal studies of children with ADHD: mental health, educational, and social outcomes. Curr. Atten. Dis. Rep. 2009; 1: 171-7.